Pharmacological analysis of the variation in behavioural responses to tryptamine in five strains of mice.
The effects of tryptamine on behaviour were studied in five strains of mice. There were significant strain differences in the intensity of the 5-HT syndrome (head weaving and hindlimb abduction) and head twitch responses. The intensity of the 5-HT syndrome correlated significantly with the brain tryptamine content, although the occurrence of head twitch was unrelated. The 5-HT2 receptor antagonist, ketanserin, antagonized the head twitch responses elicited by tryptamine without affecting the head weaving or hindlimb abduction. Metergoline, an antagonist of both the 5-HT1 and 5-HT2 receptors, strongly inhibited both the 5-HT syndrome and the head twitch responses in all five strains. [3H]5-HT and [3H]ketanserin binding in the frontal cortex of the five strains of mice was also studied. The number of [3H]5-HT binding sites did not differ among the five strains of mice although there was a noticeable difference in the number of [3H]ketanserin binding sites. These results suggest that the 5-HT syndrome and the head twitch responses induced by tryptamine are linked separately with the 5-HT1 and 5-HT2 receptors, respectively. The strain differences in the tryptamine-induced 5-HT syndrome can be explained by the different levels of brain tryptamine. The differences in the head twitch responses in the mice are probably derived from the differences in the 5-HT2 receptor binding sites in the brain and the content of brain tryptamine.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001923:Brain Chemistry / Q000187:drug effects; D007650:Ketanserin / Q000378:metabolism / Q000494:pharmacology; D008297:Male; D008711:Metergoline / Q000494:pharmacology; D051379:Mice; D008815:Mice, Inbred Strains; D012701:Serotonin / Q000378:metabolism; D013045:Species Specificity; D014363:Tryptamines / Q000494:pharmacology*
D014363:Tryptamines; D008711:Metergoline; D012701:Serotonin; D007650:Ketanserin